IS4971A - Aðferð til að greina ástand lífveru með mælingu ápeptíðum - Google Patents
Aðferð til að greina ástand lífveru með mælingu ápeptíðumInfo
- Publication number
- IS4971A IS4971A IS4971A IS4971A IS4971A IS 4971 A IS4971 A IS 4971A IS 4971 A IS4971 A IS 4971A IS 4971 A IS4971 A IS 4971A IS 4971 A IS4971 A IS 4971A
- Authority
- IS
- Iceland
- Prior art keywords
- peptides
- measuring peptides
- organism status
- analyzing
- analyzing organism
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 238000005259 measurement Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1996132521 DE19632521A1 (de) | 1996-08-13 | 1996-08-13 | Verfahren zur Gewinnung von Peptiden aus Köperflüssigkeiten und Geweben sowie Zellüberständen und zur Identifikation von krankheitsrelevanten Peptidmarkern |
| DE19725362 | 1997-06-16 | ||
| PCT/EP1997/004396 WO1998007036A1 (de) | 1996-08-13 | 1997-08-13 | Verfahren zur erfassung des status eines organismus durch messung von peptiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS4971A true IS4971A (is) | 1999-02-10 |
Family
ID=26028345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4971A IS4971A (is) | 1996-08-13 | 1999-02-10 | Aðferð til að greina ástand lífveru með mælingu ápeptíðum |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6875616B1 (is) |
| EP (1) | EP0922226B2 (is) |
| JP (1) | JP2001508864A (is) |
| CN (1) | CN1233326A (is) |
| AT (1) | ATE234469T1 (is) |
| AU (1) | AU720626B2 (is) |
| CA (1) | CA2263443C (is) |
| CZ (1) | CZ294729B6 (is) |
| DE (1) | DE59709517D1 (is) |
| DK (1) | DK0922226T3 (is) |
| EA (1) | EA001033B1 (is) |
| ES (1) | ES2191175T3 (is) |
| IS (1) | IS4971A (is) |
| PL (1) | PL186810B1 (is) |
| PT (1) | PT922226E (is) |
| WO (1) | WO1998007036A1 (is) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6936424B1 (en) * | 1999-11-16 | 2005-08-30 | Matritech, Inc. | Materials and methods for detection and treatment of breast cancer |
| DE10021737C2 (de) | 2000-05-04 | 2002-10-17 | Hermann Haller | Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird |
| US6620787B2 (en) | 2001-04-30 | 2003-09-16 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons |
| US20020160533A1 (en) | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular of weight of 1525 daltons |
| US6677303B2 (en) | 2001-04-30 | 2004-01-13 | Syn X Pharma | Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons |
| US6703366B2 (en) | 2001-04-30 | 2004-03-09 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons |
| US6599877B2 (en) | 2001-04-30 | 2003-07-29 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons |
| US6620786B2 (en) | 2001-04-30 | 2003-09-16 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having molecular weight of 2937 daltons |
| US7049397B2 (en) | 2001-04-30 | 2006-05-23 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons |
| US6627606B2 (en) | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons |
| US6627607B2 (en) | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons |
| US20020160420A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Process for diagnosis of physiological conditions by characterization of proteomic materials |
| US6593298B2 (en) | 2001-04-30 | 2003-07-15 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons |
| US6756476B2 (en) | 2001-04-30 | 2004-06-29 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons |
| US7294688B2 (en) | 2001-04-30 | 2007-11-13 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons |
| US7314717B2 (en) | 2001-04-30 | 2008-01-01 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons |
| US6602855B2 (en) | 2001-04-30 | 2003-08-05 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons |
| US6617308B2 (en) | 2001-04-30 | 2003-09-09 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons |
| US20040198950A1 (en) | 2001-04-30 | 2004-10-07 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons |
| US7015004B2 (en) * | 2001-11-23 | 2006-03-21 | Syn X Pharma, Inc. | Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
| US6890763B2 (en) | 2001-04-30 | 2005-05-10 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons |
| US7087435B2 (en) | 2001-04-30 | 2006-08-08 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons |
| US6693080B2 (en) | 2001-04-30 | 2004-02-17 | Syn X Pharma | Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons |
| US7008800B2 (en) | 2001-04-30 | 2006-03-07 | Artemis Proteomics, Ltd. | Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons |
| US6627608B2 (en) | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons |
| DE10123711A1 (de) * | 2001-05-15 | 2003-02-27 | Wolfgang Altmeyer | Verfahren zur Bestimmung der Herkunft biologischer Materialien |
| US7179610B2 (en) | 2001-11-23 | 2007-02-20 | Nanogen Inc. | Complement C3 precursor biopolymer markers indicative of insulin resistance |
| US7314762B2 (en) | 2001-11-21 | 2008-01-01 | Nanogen, Inc. | Apolipoprotein biopolymer markers indicative of insulin resistance |
| US7132244B2 (en) | 2001-11-21 | 2006-11-07 | Syn X Pharma, Inc. | Betaine/GABA transport protein biopolymer marker indicative of insulin resistance |
| US7125678B2 (en) * | 2001-11-23 | 2006-10-24 | Nanogen, Inc. | Protein biopolymer markers predictive of type II diabetes |
| US7052849B2 (en) | 2001-11-23 | 2006-05-30 | Syn X Pharma, Inc. | Protein biopolymer markers predictive of insulin resistance |
| US7074576B2 (en) | 2001-11-23 | 2006-07-11 | Syn X Pharma, Inc. | Protein biopolymer markers indicative of alzheimer's disease |
| US7179606B2 (en) | 2001-11-23 | 2007-02-20 | Syn X Pharma, Inc. | IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease |
| US6890722B2 (en) | 2001-11-23 | 2005-05-10 | Syn X Pharma, Inc. | HP biopolymer markers predictive of insulin resistance |
| US7094549B2 (en) | 2001-11-23 | 2006-08-22 | Syn X Pharma, Inc. | Fibronectin biopolymer marker indicative of insulin resistance |
| US7135297B2 (en) | 2001-11-23 | 2006-11-14 | Nanogen Inc. | Protein biopolymer markers indicative of insulin resistance |
| US20030100014A1 (en) * | 2001-11-23 | 2003-05-29 | George Jackowski | Apolipoprotein biopolymer markers predictive of type II diabetes |
| JP2005510716A (ja) * | 2001-11-23 | 2005-04-21 | シン．クス ファーマ、インコーポレイテッド | インスリン耐性を示すグロビンバイオポリマーマーカー |
| US7179605B2 (en) | 2001-11-23 | 2007-02-20 | Nanogen Inc. | Fibronectin precursor biopolymer markers indicative of alzheimer's disease |
| US7097989B2 (en) | 2001-11-23 | 2006-08-29 | Syn X Pharma, Inc. | Complement C3 precursor biopolymer markers predictive of type II diabetes |
| US7122327B2 (en) | 2001-11-23 | 2006-10-17 | Nanogen Inc. | Biopolymer markers indicative of type II diabetes |
| US7026129B2 (en) * | 2001-11-23 | 2006-04-11 | Syn X Pharma, Inc. | IG lambda biopolymer markers predictive of Alzheimers disease |
| JP2006522340A (ja) | 2003-04-02 | 2006-09-28 | メルク エンド カムパニー インコーポレーテッド | 質量分析データの分析法 |
| DE10341193A1 (de) * | 2003-09-06 | 2005-03-31 | Mosaiques Diagnostics And Therapeutics Ag | Vorrichtung und Verfahren zur quantitativen Auswertung der in einer Körperflüssigkeitsprobe enthaltenden Polypeptide sowie Marker zur Erkennung von pathologischen Zuständen |
| WO2006044666A2 (en) * | 2004-10-15 | 2006-04-27 | Northeastern University | Detection of disease associated proteolysis by direct mass spectrometry analysis of low molecular weight peptides |
| WO2009016431A1 (en) * | 2007-08-01 | 2009-02-05 | Digilab, Inc. | Sample preparation method and apparatus |
| CA2741008C (en) * | 2008-10-31 | 2018-08-28 | Biomerieux, Inc. | Methods for separation and characterization of microorganisms using identifier agents |
| CN102272602B (zh) * | 2008-10-31 | 2014-03-12 | 生物梅里埃公司 | 微生物的分离和鉴定方法 |
| AU2009320335B2 (en) * | 2008-10-31 | 2015-08-20 | Biomerieux, Inc. | Methods for separation, characterization, and/or identification of microorganisms using mass spectrometry |
| EP3792635B1 (en) * | 2012-03-30 | 2025-03-19 | BD Kiestra B.V. | A method for automatically preparing a suspension of a sample of microorganisms |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5537944A (en) * | 1978-09-09 | 1980-03-17 | Seiichi Shibata | Diagnosis chemical and diagnosis method of kidney disease |
| EP0651816A4 (en) * | 1992-07-15 | 1995-10-25 | Univ South Florida | CONTENT OF CCK PEPTIDES IN FLOWER IN RELATION TO THE TREATMENT OF PANIC RIFLES. |
| US5492834A (en) * | 1993-07-09 | 1996-02-20 | Beckman Instruments, Inc. | Method of sample preparation for urine protein analysis with capillary electrophoresis |
| DE4427531A1 (de) * | 1994-08-04 | 1996-02-08 | Forssmann Wolf Georg | Humanes zirkulierendes beta-Defensin hBD-1 |
| JP3579549B2 (ja) * | 1995-10-24 | 2004-10-20 | 株式会社トクヤマ | 糖尿病または糖尿病合併症用マーカーとしての使用 |
-
1997
- 1997-08-13 EP EP97918977A patent/EP0922226B2/de not_active Expired - Lifetime
- 1997-08-13 WO PCT/EP1997/004396 patent/WO1998007036A1/de not_active Ceased
- 1997-08-13 JP JP50940798A patent/JP2001508864A/ja not_active Ceased
- 1997-08-13 DE DE59709517T patent/DE59709517D1/de not_active Expired - Lifetime
- 1997-08-13 AU AU42988/97A patent/AU720626B2/en not_active Ceased
- 1997-08-13 PL PL97331612A patent/PL186810B1/pl not_active IP Right Cessation
- 1997-08-13 US US09/242,254 patent/US6875616B1/en not_active Expired - Fee Related
- 1997-08-13 CN CN97198763A patent/CN1233326A/zh active Pending
- 1997-08-13 DK DK97918977T patent/DK0922226T3/da active
- 1997-08-13 CZ CZ1999491A patent/CZ294729B6/cs not_active IP Right Cessation
- 1997-08-13 PT PT97918977T patent/PT922226E/pt unknown
- 1997-08-13 CA CA002263443A patent/CA2263443C/en not_active Expired - Fee Related
- 1997-08-13 EA EA199900196A patent/EA001033B1/ru not_active IP Right Cessation
- 1997-08-13 AT AT97918977T patent/ATE234469T1/de not_active IP Right Cessation
- 1997-08-13 ES ES97918977T patent/ES2191175T3/es not_active Expired - Lifetime
-
1999
- 1999-02-10 IS IS4971A patent/IS4971A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1233326A (zh) | 1999-10-27 |
| CZ49199A3 (cs) | 2000-04-12 |
| ATE234469T1 (de) | 2003-03-15 |
| EP0922226A1 (de) | 1999-06-16 |
| WO1998007036A1 (de) | 1998-02-19 |
| PT922226E (pt) | 2003-07-31 |
| US6875616B1 (en) | 2005-04-05 |
| CA2263443A1 (en) | 1998-02-19 |
| AU720626B2 (en) | 2000-06-08 |
| ES2191175T3 (es) | 2003-09-01 |
| CA2263443C (en) | 2004-03-30 |
| DK0922226T3 (da) | 2003-07-07 |
| AU4298897A (en) | 1998-03-06 |
| EP0922226B2 (de) | 2008-06-25 |
| EP0922226B1 (de) | 2003-03-12 |
| PL186810B1 (pl) | 2004-02-27 |
| DE59709517D1 (de) | 2003-04-17 |
| EA199900196A1 (ru) | 1999-06-24 |
| EA001033B1 (ru) | 2000-08-28 |
| JP2001508864A (ja) | 2001-07-03 |
| CZ294729B6 (cs) | 2005-03-16 |
| PL331612A1 (en) | 1999-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS4971A (is) | Aðferð til að greina ástand lífveru með mælingu ápeptíðum | |
| DK0901634T3 (da) | System til bestemmelse af mindst en parameter i mindst en prøve af en fysiologisk væske samt en kassette | |
| EP0805973A4 (is) | ||
| DE69930501D1 (de) | Ultrasensitive überwachung von sensoren und prozessen | |
| DE69729444D1 (de) | Nicht-invasive messung von optisch-aktiven verbindungen | |
| DE59004587D1 (de) | Messzelle für den elektrochemischen Gasnachweis. | |
| GB2344897A (en) | System and method for measuring a bioanalyte such as lactate | |
| BR9611405A (pt) | Processo e aparelho para obtenção de dados representativos do desempenho operacional de um dispositivo de controle de processo, sistema de controle para avaliação da operação de um dispositivo de controle utilizado para controlar um processo, e, processo para aquisição de dados. | |
| BG104275A (en) | Method and device for express analysis of tested parameters in biological samples | |
| DE69912899D1 (de) | Blutgerinnsel-Detektor | |
| DE69330067D1 (de) | Analytische testvorrichtung einschliesslich negativ- und positivkontrolle | |
| EA200500056A1 (ru) | Устройство, система и способ сбора геофизических данных | |
| BR0006035A (pt) | Mancal com dispositivo para detectar pulsos magnéticos de um codificador e o dispositivo compreendendo vários elementos sensores alinhados | |
| KR870004458A (ko) | 감지기 신호 처리기 검사 방법 및 장치 | |
| DE59813278D1 (de) | Korrektur von blutdruckmessungen bei invasiven flüssigkeitsgefüllten systemen | |
| NO20003709L (no) | Fremgangsmate for detektering av en analytt, og omsluttingsmiddel og kit for anvendelse deri | |
| ES2186121T3 (es) | Mejora de los resultados de los dosificados de inmunodeteccion gracias al empleo de varios trazadores. | |
| FI973561A7 (fi) | Menetelmä ja yhdisteitä analysoitavien aineiden määrittämiseksi remane nssimittausten avulla ja mainittujen yhdisteiden käyttö | |
| CY1105025T1 (el) | Αναλυση λεπτινης βασιζομενη στην ανιχνευση εκφρασης ang-2 | |
| FI875236A7 (fi) | Mittausanturi kannettavaan analysaattoriin. | |
| ATE109279T1 (de) | Sensorsystem. | |
| SE8602406D0 (sv) | Sett att bestemma densitet for underliggande lager | |
| WO1997029381A3 (de) | Verfahren und vorrichtung zur bestimmung eines kabelweges in einem kabelführungssystem einer technischen anlage sowie dabei eingesetzter detektor | |
| UA26902C2 (uk) | Спосіб перевірки ступеhя точhості або hадійhості засобів вимірюваhhя і пристрій для його здійсhеhhя | |
| DE59005231D1 (de) | Sensor für Mess- und Analysengeräte. |